Insulet (PODD) Total Debt (2010 - 2026)
Insulet's (PODD) quarterly Total Debt came in at $948.4 million in Q2 2026, down 32.24% on a YoY basis from $1.4 billion in Q2 2025, and little changed quarter-over-quarter from $948.1 million in Q1 2026.
Analysis
Insulet (PODD) Total Debt (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Total Debt for 17 consecutive years, with $948.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt fell 32.24% year-over-year to $948.4 million; the trailing twelve-month figure through Jun 2026 stood at $948.4 million (down 32.24% YoY), and the FY2025 full-year result was $949.2 million, down 31.21% from the prior year.
- Total Debt held at $948.4 million in Q2 2026 per PODD's latest filing, from $948.1 million in the prior quarter.
- Across five years, Total Debt topped out at $1.7 billion in Q1 2025 and bottomed at $948.1 million in Q1 2026.
- Historically, Total Debt has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2022.
- The sharpest annual moves came in 2022 and 2026: Total Debt jumped 33.14% in 2022, then slumped 44.08% in 2026.
- Over 5 years, Total Debt stood at $1.4 billion in 2022, then advanced by 1.0% to $1.4 billion in 2023, then decreased by 2.54% to $1.4 billion in 2024, then slumped by 31.21% to $949.2 million in 2025, then declined by 0.08% to $948.4 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $948.4 million, $948.1 million, and $949.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 28.15 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 14.94 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 12.62 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 4.15 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 2.14 Bn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 948.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 948.40 Mn |
| Mar 31, 2026 | 948.10 Mn |
| Dec 31, 2025 | 949.20 Mn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.40 Bn |
| Mar 31, 2025 | 1.70 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.40 Bn |
| Jun 30, 2024 | 1.40 Bn |
| Mar 31, 2024 | 1.40 Bn |
| Dec 31, 2023 | 1.42 Bn |
| Sep 30, 2023 | 1.42 Bn |
| Jun 30, 2023 | 1.43 Bn |
| Mar 31, 2023 | 1.42 Bn |
| Dec 31, 2022 | 1.40 Bn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 1.44 Bn |
| Mar 31, 2022 | 1.44 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Sep 30, 2021 | 1.31 Bn |